5 Stocks to Buy with Exponential Growth

3. Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)

Average Sales Growth Over the Past 5 Years: 7580%

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) shares have gained about 13% over the past one year. In August Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) posted second quarter results. Adjusted EPS in the quarter came in at -$0.45, beating estimates by $0.14. Revenue jumped 99% in the period to $110.8 million, surpassing estimates by $3.99 million.

Insider Monkey’s database of 910 hedge funds shows that 32 hedge funds had stakes in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). The most significant stakeholder of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) was Brandon Haley’s Holocene Advisors which owns an $107 million stake in the company.